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Introduction: Video-assisted thoracic sympathectomy (VATS) is one minimally invasive definitive treatment for axillary
hyperhidrosis. Different techniques exist for controlling axillary sudoresis, but they are temporary and have high cost.
This study was conducted to compare the initial results from sympathectomy using two distinct levels for treating axillary
sudoresis: T3-T4 vs T4.
Methods: Sixty-two patients with axillary hyperhidrosis were prospectively randomized for denervation of T3-T4 or T4 alone.
All patients were examined preoperatively and were followed-up at 1 and 6 months postoperatively. Evaluated were the axillary
hyperhidrosis treatment, the presence, location, and severity of compensatory hyperhidrosis, and the quality of life.
Results: All the patients said that their axillary hyperhidrosis was successfully treated by the surgery after 6 months. There
was no treatment failure. Compensatory hyperhidrosis was present in 29 patients (90.6%) of the T3-T4 group and in 17
T4 patients (56.7%) after 1 month. After 6 months, all the T3-T4 patients presented some degree of compensatory
hyperhidrosis vs 13 T4 patients (43.3%). The severity of the compensatory hyperhidrosis was also lower in the T4 patients
(P< . 01). The quality of life was poor in both groups before the surgery, and was equally improved in both groups after
1 and 6 months of follow-up. There were no deaths or significant postoperative complications nor a need for conversion
to thoracotomy.
Conclusion: Both techniques are effective for treating axillary hyperhidrosis, but the T4 group presented milder
compensatory hyperhidrosis and had a greater satisfaction rate. ( J Vasc Surg 2007;45:130-3.)Axillary hyperhidrosis is an important problem that
may lead to serious emotional and occupational distur-
bances. Local treatment and psychotherapy offer low effec-
tiveness. Injection of botulinum toxin offers good results,
but only temporarily (6 months), and excision/resection
of the eccrine sweat glands frequently presents low efficacy
and high recurrence rates compared with sympathectomy. 1-9
Video-assisted thoracic surgery (VATS) sympathec-
tomy is a recognized procedure for the definitive treatment
of palmar hyperhidrosis, but doubts still exist about its
efficacy for treating axillary hyperhidrosis. To date, no
randomized and prospective studies have compared VATS
sympathectomy results from treating axillary hyperhidrosis
by means of different levels of thermoablation of the sym-
pathetic chain. The objective of the present study was to
compare the results (6 months) from the use of VATS
sympathectomy at two resection levels, T3-T4 vs T4, in a
prospective and randomized manner. The efficacy of the
axillary hyperhidrosis treatment, the presence and severity
of compensatory hyperhidrosis, and the patients’ satisfac-
tion were evaluated.
METHODS
From May 2004 to July 2006, 62 patients with pure
axillary hyperhidrosis (without palmar or facial hyperhidro-
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130sis) who underwent a VATS sympathectomy were studied
prospectively and randomly. The institutional protocol ap-
plied to the patients was in accordance with the principles of
the Ethics Committee for Analysis of Research Projects on
Human Experimentation.
The criterion for inclusion in the study was a complaint
of axillary hyperhidrosis with the intention of undergoing
surgery after information about the risks and chances of
compensatory hyperhidrosis was presented. The exclusion
criteria were the existence of previous thoracic surgery or
associated diseases, such as cardiac diseases, pulmonary
infections, neoplasias, or diseases of the pleura or lungs that
could increase the surgical risks, or when the patient’s body
mass index (BMI) was 25.10
Patients were randomized individually into two groups
by using a randomization table: 32 patients underwent
VATS sympathectomy with resection of the T3-T4 ganglia,
and 30 patients underwent resection of the T4 ganglion
alone. All the procedures were done by the same surgical
team and with a standardized technique.
All the patients underwent the operation under general
anesthesia and alternated selective intubation and pulmo-
nary ventilation. Two incisions were used in each hemitho-
rax: the first into the fourth intercostal space at the anterior
axillary line and the second into the third intercostal space
at the medial axillary line.11
After each sympathetic chain was identified, the pa-
tients randomized into the T3-T4 group underwent sym-
pathicectomy on the bodies of the third, fourth, and fifth
ribs, followed by thermoablation of the segments isolated
between them. The patients randomized into the T4 group
underwent resection of the chain (sympathicectomy) at the
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between them. After the sympathectomy, the lung was
re-expanded under direct viewing and a small catheter
(16F)was used to aspirate air from the pleural space. The same
procedurewas doneon the contralateral chain.Theuse a chest
drain was not routine. Lung expansion after the operation
was assessed with a chest radiograph.
All the patients were re-valuated as outpatients at 1 and
6 months after the procedure. The observers recording the
findings were blinded to patient’s treatment. Assessed were
(1) the presence or absence of axillary hyperhidrosis re-
ported by the patient and confirmed by the examiner and
(2) the presence or absence of compensatory hyperhidrosis
and its location and severity, again reported by the patient
and confirmed by the examiner.
The severity of the sudoresis was graded as three levels:
mild, moderate, or severe:
● Mild compensatory sweating was considered present
when patients reported minor modifications in the
location and severity of their sweating, such as visible
sweating, but without expressing significant concern
about this.
● Moderate compensatory hyperhidrosis was considered
present when patients reported visible and embarrass-
ing sweating or occasionally disabling situations caused
by sweating.
● Severe compensatory hyperhidrosis was considered
present when patients reported interference in their
social and professional activities, such as the need for
successive changes of clothes caused by sweating at the
same intensity as their previous axillary hyperhidrosis
but at other primary locations. It was defined as severe
when it was visible, embarrassing, and led to at least
one change of clothes during the day.
● Patients who did not notice any difference in the
location or severity of their body sweating were con-
sidered to be unaffected by compensatory hyperhi-
drosis.
The patients’ satisfaction ratings on the final result from
the procedure, including both the treatment and any com-
plications, was subjectively evaluated bymeans of amultiple
choice subjective rating scale (four options) in which the
patients could place themselves on a satisfaction scale as
follows: 1, deficient (dissatisfied); 2, regular; 3, very good;
4, excellent.
Statistical analysis. For categoric variables, the 2 or
Fisher’s exact frequencies test were used, depending on the
sample, for verifying associations between the type of sur-
gery and the possible results and complications. These
statistical tests for comparing the types of surgery with the
variables of interest (axillary hyperhidrosis, incidence and
severity of compensatory hyperhidrosis, and satisfaction)
were performed in relation to each of the assessment peri-
ods. The associations between patients’ ages, degrees of
satisfaction, and ganglion resection level (T3-T4 or T4)
were investigated using the Mann-Whitney U test. The
significance level considered for all tests was P  0.05.RESULTS
The mean age and male/female proportions in the two
groups were similar (Table I). Fifty-nine patients (95.16%)
were discharged on the day after the surgery, and the
remaining three patients (4.84%) were discharged 48 hours
after the operation.
No cases of axillary hyperhidrosis were reported during
the immediate postoperative period for either group, nor
was Horner syndrome reported. Pleural drainage was nec-
essary in three patients of the T3-T4 group because of
significant pleural adherence. No recurrence of axillary
hyperhidrosis in either of the groups was reported at the
1-month and 6-month follow-up.
The incidence and severity of compensatory hyperhi-
drosis are presented in Table II. The incidence of compen-
satory hyperhidrosis was lower in T4 group, both after 1
month and 6 months of follow-up. The severity of com-
pensatory hyperhidrosis was lower in the T4 group, and no
severe compensatory hyperhidrosis was noted at the
1-month and 6-month follow-ups in this group.
Patients who underwent T3-T4 resection maintained
their compensatory hyperhidrosis rates during that time,
whereas the incidence and severity of compensatory hy-
perhidrosis decreased from 1 to 6 months in the T4
group. The location of the compensatory hyperhidrosis
did not differ between the two groups: the abdomen,
back and legs were the regions most affected. No differ-
ence was noted in the triggering situations: most (21
in the T3-T4 group and 12 in T4) reported compensa-
tory hyperhidrosis related to heat and intense physical
activity.
The patients’ satisfaction rates are presented in Table III.
Patients of groups presented similar satisfaction rates. It
needs to be emphasized that there were no dissatisfied
patients in the T4 group and one patient in T3-T4 group
Table I. Patient clinical characteristics
T3-T4 T4 P
Mean age 25.06 (8.90) 26.67(4.77) .189
Men/women 10:22 4:26 .092
Table II. Incidence and severity of compensatory
hyperhidrosis following surgery
Group
1 month* 6 months*
Absent Mild
Moderate/
severe Absent Mild
Moderate/
severe
T3/T4 3 14 15 4 17 11
T4 13 16 1 17 11 2
*Level of statistical significance according to 2 test for these data is P 
.001.after 6 months.
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Axillary hyperhidrosis is a frequent condition that af-
fects 23% of our operated patients. The great psychosocial
disturbances among such patients lead to restrictions both
on private life and social life. The efficacy of sympathectomy
for treating palmar hyperhidrosis has been known for de-
cades. With the use of thoracoscopy equipment enabling
small incisions, this surgical procedure has largely come to
present excellent results, with low morbidity, rapid postop-
erative recovery, and imperceptible scars.12
The initial results using VATS sympathectomy for
treating axillary hyperhidrosis were good in only 68% to
89% of the cases.13,14 With technical progress and the
resection of lower ganglion levels (third and fourth gan-
glia), the results have become better, reaching a success rate
of 94%.15 We observed that both the T3-T4 and T4 resec-
tions were effective in all patients in our study. The main
reason for obtaining these good results was the extreme
care taken in identifying and resecting the correct ganglia,
accomplished by an experienced specialized team16 with
1500 bilateral surgical procedures.
One problem that has been found in several case series
is the degree of recurrent axillary hyperhidrosis, which has
ranged from 15%17 to 65%.18,19 In our series, we did not
find any cases of recurrence in either group after 6 months
of follow-up. The lack of recurrence observed in the study
is due to the absence of technical failure among the patients
operated.
The most frequent locations for compensatory hyper-
hidrosis described in the literature, and corroborated by
our study, are the abdomen, back, feet, and gluteal region.
In most cases, it is tolerable and does not lead to social
disturbances or occupational disability. Patients are only
inconvenienced when their symptoms are severe or when
they do not receive adequate information before the oper-
ation. Patients must always be warned about this possible
complication before the surgery because of the irreversibil-
ity of the method.
Resection of the T4 ganglion seems to be the key to
these good results.20 Our data demonstrate that T5 resec-
tion is not necessary, as recommended by other au-
thors.13,20 For T4 ganglion resection, a complete operation
on T4 is necessary, consisting of sympathicectomy on the
upper margin of the fourth rib and the lower margin of the
fifth rib, and also thermoablation of the chain between
Table III. Patient satisfaction rates
Group
1 month* 6 months*
Completely
satisfied
Moderately
satisfied
Completely
satisfied
Moderately
satisfied
T3/T4 28 4 28 3
T4 29 1 29 1
*Level of statistical significance according to Fisher’s exact test for these data
is P  .355.these points.21 Through this, we have achieved satisfactionrates after 6 months that are better than for the T3-T4
group and similar to published reports for T4 sympathec-
tomy.16,22,23
With the advent of VATS sympathectomy, Horner
syndrome has become a rare complication.17,18,24 Its oc-
currence is now limited to indirect lesions of the stellate
ganglion that are caused by diffusion of heat or excessive
traction on the sympathetic chain. Because only the T3 and
T4 ganglia were manipulated, we did not have this type of
complication, regardless of the type of scalpel used (har-
monic or electric). It is important to take care with manip-
ulations on the left-side upper margin of the fifth rib
because the thoracic duct crosses the aorta posteriorly at
this location.
Compensatory hyperhidrosis is the complication most
commonly related to VATS sympathectomy.22-25 When
the T2, T3, and T4 ganglia (more extensive and higher
level) are resected, the occurrence of compensatory hyper-
hidrosis may reach 89% of the patients, with a high inci-
dence of severe compensatory hyperhidrosis (35%).22 In
our series, with resection of lower levels, we found that
87.5% of the patients in the T3-T4 group and 43.3% in the
T4 group presented this complication after 6 months. A
lower incidence of compensatory hyperhidrosis of 8.5% was
observed by Neumayer et al,25 but this difference was due
to the classification used for grading compensatory hyper-
hidrosis.
By stratifying the severity, we found another large
statistical difference. In the T3-T4 group, compensatory
hyperhidrosis of moderate or severe nature accounted for
34.4% of the group, whereas in the T4 group, only 6.7% of
the patients had moderate compensatory hyperhidrosis and
there were no severe cases. This leads us to believe that
thermoablation of T3 is unnecessary.
We observed that mild compensatory hyperhidrosis
increased from 14 to 17 cases between the 1-month and
6-month follow-up evaluations for the T3-T4 group, but
more serious cases decreased. On the other hand, in the T4
group the number of mild cases decreased from 16 to 11
because many patients started to feel that they were free of
these effects.
We did not use any objective measurement of the
sudoresis because these methods can show only informa-
tion at a single time point. There are no methods that can
measure hyperhidrosis for all-day period.
CONCLUSION
Despite the presence of compensatory hyperhidrosis,
an improvement in quality of life was found for our entire
series. The satisfaction rate was high in both groups, with-
out statistical difference, both at the 1-month and 6-month
follow-up. Long-term follow-up for these two groups may
show whether these results will be maintained over time. In
the event of late return of symptoms among the patients in
the T4 group, it would be possible to operate on them again
and extend the sympathectomy to the T3 ganglion.26,27
Resection of the T4 ganglion is preferable to resection
of the T3 and T4 ganglia together, because despite their
JOURNAL OF VASCULAR SURGERY
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tion gives a lower rate of compensatory hyperhidrosis.
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